These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3296152)
21. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854 [TBL] [Abstract][Full Text] [Related]
22. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study. Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226 [TBL] [Abstract][Full Text] [Related]
23. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome. Saraux A Autoimmun Rev; 2010 Jul; 9(9):609-14. PubMed ID: 20452466 [TBL] [Abstract][Full Text] [Related]
24. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737 [TBL] [Abstract][Full Text] [Related]
25. Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome. Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S Tokai J Exp Clin Med; 1988 Aug; 13(3):165-9. PubMed ID: 2978189 [TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome. Kaufman I; Schwartz D; Caspi D; Paran D Scand J Rheumatol; 2008; 37(3):213-8. PubMed ID: 18465457 [TBL] [Abstract][Full Text] [Related]
27. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group. Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998 [No Abstract] [Full Text] [Related]
28. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Cummins MJ; Papas A; Kammer GM; Fox PC Arthritis Rheum; 2003 Aug; 49(4):585-93. PubMed ID: 12910567 [TBL] [Abstract][Full Text] [Related]
37. Lamivudine is not effective in primary Sjögren's syndrome. Gescuk B; Wu AJ; Whitcher JP; Daniels TE; Lund S; Fye K; Davis JC Ann Rheum Dis; 2005 Sep; 64(9):1326-30. PubMed ID: 15708886 [TBL] [Abstract][Full Text] [Related]
38. [Transient, prolonged, combined sicca syndrome of the eyes and mouth. Occurrence along with a common cold in an 8-year-old girl]. Rebmann H; Rohrbach JM; Riester A Monatsschr Kinderheilkd; 1992 Aug; 140(8):457-9. PubMed ID: 1435804 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial. Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532 [TBL] [Abstract][Full Text] [Related]
40. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome. Shiozawa S; Tanaka Y; Shiozawa K J Interferon Cytokine Res; 1998 Apr; 18(4):255-62. PubMed ID: 9568728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]